Stay updated on Etripamil Nasal Spray for SVT: Clinical Trial
Sign up to get notified when there's something new on the Etripamil Nasal Spray for SVT: Clinical Trial page.

Latest updates to the Etripamil Nasal Spray for SVT: Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions about the Open Label Extension study for Etripamil Nasal Spray in patients with Paroxysmal Supraventricular Tachycardia (PSVT) and the addition of a new revision number.SummaryDifference41%
- Check42 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 12, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.2%
- Check64 days agoChange DetectedThe webpage has updated its date references, removing older dates from January 2024 and adding new dates in March and June 2025.SummaryDifference1%
- Check85 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check100 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Etripamil Nasal Spray for SVT: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etripamil Nasal Spray for SVT: Clinical Trial page.